Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Soins. Gerontologie|September 18, 2017
[Checkpoint inhibitors, the perspectives for elderly patients]Thierry Landre, Fatima Karaoud, Cherifa TalebCancers|April 3, 2021
Impact on All-Cause and Cardiovascular Mortality Rates of Coronary Artery Calcifications Detected during Organized, Low-Dose, Computed-Tomography Screening for Lung Cancer: Systematic Literature Review and Meta-AnalysisSébastien Gendarme, Helene Goussault, Jean-Baptiste Assié, et al.Journal of Cancer Research and Clinical Oncology|November 6, 2019
First-line PD-1/PD-L1 inhibitor plus chemotherapy vs chemotherapy alone for negative or < 1% PD-L1-expressing metastatic non-small-cell lung cancersThierry Landre, Gaetan Des Guetz, Kader Chouahnia, et al.Soins. Gerontologie|February 16, 2013
[Assessment of nursing needs and risk management in geriatric oncology]Cherifa Taleb, Thierry Landre, Eric Bertrand, et al.Clinical Genitourinary Cancer|June 23, 2019
Is There a Benefit of Addition Docetaxel, Abiraterone, Celecoxib, or Zoledronic Acid in Initial Treatments for Patients Older Than 70 Years With Hormone-sensitive Advanced Prostate Cancer? A Meta-analysisThierry Landre, Gaetan Des Guetz, Kader Chouahnia, et al.Nutrients|March 29, 2023
Prevalence of Four Sarcopenia Criteria in Older Patients with Cancer, and Their Predictive Value for 6-Month Mortality: The NutriAgeCancer National Prospective Cohort StudyClaudia Martinez-Tapia, Kevin Rougette, Virginie Fossey-Diaz, et al.Pageof 1